Organizing Committee
Prof. Michal Lotem
The Founder and Head of the Hadassah Cancer Research Institute, Professor Michal Lotem is an international expert in skin cancer and clinical oncology, driving cutting-edge scientific innovation at the HCRI since its inception in 2019. Her vision for HCRI is to investigate the nature of various cancers and enable HRCI’s physicians, scientists and researchers to develop new and personalized ways to manipulate the immune system to cure cancer, with the goal of eradicating cancer.
Prof. Claudio Sette
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Prof. Rotem Karni
Hebrew University-Hadassah Medical School, Jerusalem, IL, and University of Pennsylvania, USA
Dr. Ernesto Guccione
Dr. Guccione started his independent lab at A*STAR in Singapore in 2008 and since 2019 has been a Professor at Mount Sinai Icahn School of Medicine where he is the director of the Mount Sinai Center for OncoGenomics and Innovative Therapeutics (COGIT).
Dr. Guccione has a long-standing interest in understanding basic mechanisms of transcriptional and post-transcriptional (e.g. splcing) regulation in order to identify therapeutic opportunities in oncology.
In particular he focused his research on dissecting the role of oncogenic Protein Methyltransferases (PMTs), and on the design and testing of Antisense Oligonucleotides (ASOs).
